Literature DB >> 18505851

Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.

Pattarachai Kiratisin1, Anucha Apisarnthanarak, Chaitat Laesripa, Piyawan Saifon.   

Abstract

Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae have rapidly spread worldwide and pose a serious threat for health care-associated (HA) infection. We conducted molecular detection and characterization of ESBL-related bla genes, including bla(TEM), bla(SHV), bla(CTX-M), bla(VEB), bla(OXA), bla(PER), and bla(GES), among 362 isolates of ESBL-producing E. coli (n = 235) and ESBL-producing K. pneumoniae (n = 127) collected from patients who met the definition of HA infection at two major university hospitals in Thailand from December 2004 to May 2005. The prevalence of ESBL-producing E. coli and ESBL-producing K. pneumoniae, patient demographics and the susceptibilities of these bacteria to various antimicrobial agents were described. A total of 87.3% of isolates carried several bla genes. The prevalence of bla(CTX-M) was strikingly high: 99.6% for ESBL-producing E. coli (CTX-M-14, -15, -27, -40, and -55) and 99.2% for ESBL-producing K. pneumoniae (CTX-M-3, -14, -15, -27, and -55). ISEcp1 was found in the upstream region of bla(CTX-M) in most isolates. Up to 77.0% and 71.7% of ESBL-producing E. coli and ESBL-producing K. pneumoniae, respectively, carried bla(TEM); all of them encoded TEM-1. ESBL-producing K. pneumoniae carried bla(SHV) at 87.4% (SHV-1, -2a, -11, -12, -27, -71, and -75) but only at 3.8% for ESBL-producing E. coli (SHV-11 and -12). bla genes encoding VEB-1 and OXA-10 were found in both ESBL-producing E. coli (8.5% and 8.1%, respectively) and ESBL-producing K. pneumoniae (10.2% and 11.8%, respectively). None of the isolates were positive for bla(PER) and bla(GES). Pulsed-field gel electrophoresis analysis demonstrated that there was no major clonal relationship among these ESBL producers. This is the first study to report CTX-M-3, CTX-M-27, CTX-M-40, SHV-27, SHV-71, and SHV-75 in Thailand and to show that CTX-M ESBL is highly endemic in the country.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505851      PMCID: PMC2493136          DOI: 10.1128/AAC.00171-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.

Authors:  Laurent Poirel; Marek Gniadkowski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

Review 2.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

3.  Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa.

Authors:  T Naas; L Poirel; A Karim; P Nordmann
Journal:  FEMS Microbiol Lett       Date:  1999-07-15       Impact factor: 2.742

4.  Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).

Authors:  Yoichi Hirakata; Junichi Matsuda; Yoshitsugu Miyazaki; Shimeru Kamihira; Sayoko Kawakami; Yukihisa Miyazawa; Yasuo Ono; Nobuhiko Nakazaki; Yasuyoshi Hirata; Matsuhisa Inoue; John D Turnidge; Jan M Bell; Ronald N Jones; Shigeru Kohno
Journal:  Diagn Microbiol Infect Dis       Date:  2005-08       Impact factor: 2.803

5.  CTX-M extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae in a Thai university hospital.

Authors:  Aroonwadee Chanawong; Aroonlug Lulitanond; Wanlop Kaewkes; Viraphong Lulitanond; Sukanya Srigulbutr; Preecha Homchampa
Journal:  Southeast Asian J Trop Med Public Health       Date:  2007-05       Impact factor: 0.267

6.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

7.  Identification and characterization of ceftriaxone resistance and extended-spectrum beta-lactamases in Malawian bacteraemic Enterobacteriaceae.

Authors:  Katherine J Gray; Lorna K Wilson; Amos Phiri; John E Corkill; Neil French; C Anthony Hart
Journal:  J Antimicrob Chemother       Date:  2006-04       Impact factor: 5.790

8.  A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.

Authors:  Enno Stürenburg; Alexandra Kühn; Dietrich Mack; Rainer Laufs
Journal:  J Antimicrob Chemother       Date:  2004-06-16       Impact factor: 5.790

9.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Authors:  N Woodford; M E Ward; M E Kaufmann; J Turton; E J Fagan; D James; A P Johnson; R Pike; M Warner; T Cheasty; A Pearson; S Harry; J B Leach; A Loughrey; J A Lowes; R E Warren; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

10.  Spread of bla(CTX-M-type) and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian hospitals.

Authors:  Giuseppe Celenza; Cristina Pellegrini; Marisa Caccamo; Bernardetta Segatore; Gianfranco Amicosante; Mariagrazia Perilli
Journal:  J Antimicrob Chemother       Date:  2006-03-01       Impact factor: 5.790

View more
  58 in total

1.  Characterization of the First OXA-10 Natural Variant with Increased Carbapenemase Activity.

Authors:  Stathis D Kotsakis; Carl-Fredrik Flach; Mohammad Razavi; D G Joakim Larsson
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract.

Authors:  Adrian J Brink; Jennifer Coetzee; Craig Corcoran; Cornelis G Clay; Danusha Hari-Makkan; Rachael K Jacobson; Guy A Richards; Charles Feldman; Louise Nutt; Johan van Greune; J D Deetlefs; Karin Swart; Lesley Devenish; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

3.  Molecular characterization of β-lactam-resistant Escherichia coli isolated from Fu River, China.

Authors:  Li-Kou Zou; Li-Wen Li; Xin Pan; Guo-Bao Tian; Yan Luo; Qi Wu; Bei Li; Lin Cheng; Jiu-Jing Xiao; Su Hu; Yang Zhou; Yu-Juan Pang
Journal:  World J Microbiol Biotechnol       Date:  2012-01-26       Impact factor: 3.312

4.  In vitro activity of ceftolozane-tazobactam as determined by broth dilution and agar diffusion assays against recent U.S. Escherichia coli isolates from 2010 to 2011 carrying CTX-M-type extended-spectrum β-lactamases.

Authors:  Mark Estabrook; Brianne Bussell; Susan L Clugston; Karen Bush
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

5.  Spread of extended-spectrum beta-lactamase-producing Escherichia coli from a swine farm to the receiving river.

Authors:  Song Li; Wengang Song; Yufa Zhou; Yujing Tang; Yanxia Gao; Zengmin Miao
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-30       Impact factor: 4.223

6.  Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain.

Authors:  Aránzazu Valverde; Rafael Cantón; M Pilar Garcillán-Barcia; Angela Novais; Juan Carlos Galán; Andrés Alvarado; Fernando de la Cruz; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

7.  The sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. Circulating in Southern Vietnam.

Authors:  Nhu Thi Khanh Nguyen; Vinh Ha; Nga Vu Thieu Tran; Richard Stabler; Duy Thanh Pham; Thi Minh Vien Le; H Rogier van Doorn; Ana Cerdeño-Tárraga; Nicholas Thomson; James Campbell; Van Minh Hoang Nguyen; Thi Thu Nga Tran; Minh Van Pham; Thuy Thu Cao; Brendan Wren; Jeremy Farrar; Stephen Baker
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

8.  Prevalence and antibiogram of Extended Spectrum β-Lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp.

Authors:  Meeta Sharma; Sati Pathak; Preeti Srivastava
Journal:  J Clin Diagn Res       Date:  2013-10-05

9.  Simultaneous gut colonisation and infection by ESBL-producing Escherichia coli in hospitalised patients.

Authors:  Johny Asir; Shashikala Nair; Sheela Devi; Kenchappa Prashanth; Rajagopalan Saranathan; Reba Kanungo
Journal:  Australas Med J       Date:  2015-06-30

10.  Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia.

Authors:  Mohammad H M Al-Agamy; Atef M Shibl; Abdelkader F Tawfik
Journal:  Ann Saudi Med       Date:  2009 Jul-Aug       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.